Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical retapamulin in pediatric uncomplicated skin infections
2006-003374-10Phase 3Completed
- Sponsor
- GSK
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of retapamulin in skin and soft tissue infections (SSTIs), impetigo, Wound infection (WI) and 1 more, sponsored by GSK. Primary endpoints: Pharmacokinetic endpoint, Safety and tolerability and 1 more. Started May 2007; status: completed.
02
Drugs
retapamulin
03
Conditions
skin and soft tissue infections (SSTIs)impetigoWound infection (WI)infected dermatosis
Beyond the preview
Go deeper on 2006-003374-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003374-10.